4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:Elisa试剂盒,单克隆多克隆抗体蛋白
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > peptide > avivasysbio/AKT1抗体(磷酸化Ser473)(OAAB01820)/400ul/OAAB01820
商品详细avivasysbio/AKT1抗体(磷酸化Ser473)(OAAB01820)/400ul/OAAB01820
avivasysbio/AKT1抗体(磷酸化Ser473)(OAAB01820)/400ul/OAAB01820
avivasysbio/AKT1抗体(磷酸化Ser473)(OAAB01820)/400ul/OAAB01820
商品编号: OAAB01820
市场价: ¥8580.00
美元价: 5148.00
产地: 美国(厂家直采)
公司:
产品分类: 多肽合成
公司分类: peptide
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
Basic Info
More Information
Predicted Species ReactivityHuman
Product FormatLiquid. PBS with 0.09% (W/V) sodium azide.
ClonalityPolyclonal
IsotypeRabbit Ig
HostRabbit
ApplicationDB, WB
::Function: AKT1 is one of 3 closely related serine/threonine- protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at "Ser-50" negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT regulates also the storage of glucose in the form of glycogen by phosphorylating GSK3A at "Ser-21" and GSK3B at "Ser-9", resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT regulates also cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation of "Ser-83" decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at "Ser-939" and "Thr-1462", thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In particular, FOXO1 is phosphorylated at "Thr-24", "Ser-256" and "Ser-319". FOXO3 and FOXO4 are phosphorylated on equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)- response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates "Ser-454" on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of "Ser-273", resulting in reduced cyclic AMP levels and inhibition of lipolysis. Phosphorylates PIKFYVE on "Ser-318", which results in increased PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I). AKT mediates the antiapoptotic effects of IGF-I. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. May be involved in the regulation of the placental development. Phosphorylates STK4/MST1 at "Thr-120" and "Thr-387" leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at "Thr- 117" and "Thr-384" leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation. Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation. Phosphorylates RAF1 at "Ser-259" and negatively regulates its activity. Phosphorylation of BAD stimulates its pro- apoptotic activity. Phosphorylates KAT6A at "Thr-369" and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53.Cellular Location: Cytoplasm. Nucleus. Cell membrane. Note=Nucleus after activation by integrin-linked protein kinase 1 (ILK1). Nuclear translocation is enhanced by interaction with TCL1A. Phosphorylation on Tyr-176 by TNK2 results in its localization to the cell membrane where it is targeted for further phosphorylations on Thr-308 and Ser-473 leading to its activation and the activated form translocates to the nucleus.Tissue Location Expressed in prostate cancer and levels increase from the normal to the malignant state (at protein level). Expressed in all human cell types so far analyzed. The Tyr-176 phosphorylated form shows a significant increase in expression in breast cancers during the progressive stages i.e normal to hyperplasia (ADH), ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC) and lymph node metastatic (LNMM) stages.
Reconstitution and StorageMaintain refrigerated at 2-8C for up to 2 weeks. For long term storage store at -20C in small aliquots to prevent freeze-thaw cycles.
Replacement ItemThis antibody may replace item sc-101629 from Santa Cruz Biotechnology.
ImmunogenThis Phospho-AKT1-pS473 antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding S473 of human AKT1.
PurificationThis antibody is purified through a protein A column, followed by peptide affinity purification.
Predicted Homology Based on Immunogen SequenceHuman
ConcentrationApproximately 0.5mg/ml. Actual concentration varies with each lot.
Datasheets/ManualsPrintable datasheet for anti-AKT1 antibody - OAAB01820
Intended UseFor research use only and not for use in diagnostic or therapeutic procedures.
Application InfoDB: 1:500WB: 1:1000
Target Info
Gene SymbolAKT1
Alias SymbolsRAC-alpha serine/threonine-protein kinase, RAC-PK-alpha, Protein kinase B, PKB, C-AKT, AKT1, PKB, RAC
NCBI Gene Id207
Protein NameRAC-alpha serine/threonine-protein kinase
Description of TargetThe serine-threonine protein kinase encoded by the AKT1 gene is catalytically inactive in serum-starved primary and immortalized fibroblasts. AKT1 and the related AKT2 are activated by platelet-derived growth factor. The activation is rapid and specific, and it is abrogated by mutations in the pleckstrin homology domain of AKT1. It was shown that the activation occurs through phosphatidylinositol 3-kinase. In the developing nervous system AKT is a critical mediator of growth factor-induced neuronal survival. Survival factors can suppress apoptosis in a transcription-independent manner by activating the serine/threonine kinase AKT1, which then phosphorylates and inactivates components of the apoptotic machinery.
Swissprot IdP31749
Protein Accession #NP_001014431.1
Molecular Weight55716 Da
Tissue ToolFind tissues and cell lines supported by DNA array analysis to express AKT1.
RNA SeqFind tissues and cell lines supported by RNA-seq analysis to express AKT1.
Protocols & Data
Protocol:
  • Reconstitution & Storage Instructions
  • Western Blotting/Immunoblotting (WB/IB) Protocol
  • Immunohistochemistry (IHC) Protocol
  • Immunocytochemistry (ICC) Protocol
  • Enzyme-Linked ImmunoSorbent Assay (ELISA) Protocol
  • Blocking Peptide Competition Protocol (BPCP)
  • Immunoprecipitation (IP) Protocol
  • Antibody Array (AA) Protocol
Tips Information:
  • IHC Tips & Tricks
  • ICC Tips & Tricks
  • ELISA Tips & Tricks
  • WB/IB Tips & Tricks
  • IP Tips & Tricks

See our General FAQ page.

Related Categories
Product FAQ
  1. What is the species homology for "AKT1 Antibody (Phospho-Ser473) (OAAB01820)"?

    The tested species reactivity for this item is "". This antibody is predicted to have homology to "Human".

  2. How long will it take to receive "AKT1 Antibody (Phospho-Ser473) (OAAB01820)"?

    This item is available "Domestic: within 1 week delivery | International: 1 week".

  3. What buffer format is "AKT1 Antibody (Phospho-Ser473) (OAAB01820)" provided in?

    This item is provided in "Liquid. PBS with 0.09% (W/V) sodium azide. ".Additional format options may be available. For more information please contact info@avivasysbio.com.

  4. What are other names for "AKT1 Antibody (Phospho-Ser473) (OAAB01820)"?

    This target may also be called "RAC-alpha serine/threonine-protein kinase, RAC-PK-alpha, Protein kinase B, PKB, C-AKT, AKT1, PKB, RAC" in publications.

  5. What is the shipping cost for "AKT1 Antibody (Phospho-Ser473) (OAAB01820)"?

    The shipping cost for this item is $40 within the US. Please contact us for specific shipping prices for international orders.

  6. What is the guarantee for "AKT1 Antibody (Phospho-Ser473) (OAAB01820)"?

    All Aviva products have been through rigorous validations and carry 100% satisfaction guarantee.

  7. Can I get bulk pricing for "AKT1 Antibody (Phospho-Ser473) (OAAB01820)"?

    You can get bulk pricing for this item by going here.

  8. What is the molecular weight of the protein?

    The molecular weight reported by Uniprot for this item is "55716 Da".Please note observed molecular weights in western blot applications may differ depending on a variety of protein characteristics.

  9. What protocols are available for "AKT1 Antibody (Phospho-Ser473) (OAAB01820)"?

    We may have detailed protocol data avaialble for this item. To learn more, please view the "Protocols & Data" tab on the product page.

  10. What are positive controls for "AKT1"?

    We have listed RNA Seq and gene expression data in the "Target Info" tab. You may be able to find adequate positive controls there.

  11. What are negative controls for "AKT1"?

    We have listed RNA Seq and gene expression data in the "Target Info" tab. You may be able to find adequate positive controls there.

  12. What other proteins interact with "AKT1"?

    This protein has been reported to interact with "Protein Interactions". Please view the "Related Categories" tab on the product page for more information.

  13. What biological processes are associated with "AKT1"?

    This protein has been associated with "Biological Processes". Please view the "Related Categories" tab on the product page for more information.

  14. What cellular components are associated with "AKT1"?

    This protein has been associated with "Cellular Components". Please view the "Related Categories" tab on the product page for more information.

  15. What protein functions are associated with "AKT1"?

    This protein has been associated with "Protein Functions". Please view the "Related Categories" tab on the product page for more information.

Reviews 1
Write Your Own Review
品牌介绍
avivasysbioVytas P. Ambutas- 董事会主席Ambutas先生是一家多元化的工业控股公司National Material LP的总法律顾问,秘书兼法律和行政副总裁。Ambutas先生是Tang Industries,Inc.的总法律顾问,Tang Industries,Inc.是一家多元化控股公司,包括工业,制药,家具和房地产控股公司,并担任高强度碳素钢加工商Nacme Steel Processing,LLC的董事,以及Key Colony,Inc.,果汁产品的制造商和分销商。Ambutas先生从1980年至1992年曾从事私人执业。Ambutas先生拥有芝加哥洛约拉法学院的法学博士学位和西密歇根大学的学士学位。朱利安- 董事会成员朱利安·袁(Julian Yuan)是联合创始人兼董事会成员。袁先生还是英杰华生物科技公司的联合创始人和董事会成员。袁先生自1983年成立以来,一直担任Progressive Group Inc.(PGI)的总裁兼首席执行官。PGI是其中之一。台湾最大的医疗器械经销商。袁先生是一位企业家,在生物科学产品,医疗设备和仪器的管理和营销方面拥有22年的经验。袁先生于1979年在台湾中原大学获得化学学士学位。Patrick Liang- 董事会成员梁先生现任唐实业有限公司中国业务董事总经理兼唐投资集团(中国)有限公司总裁。之前,梁先生曾任中国材料有限公司总经理,SKD中国副总裁,以及Irvine Networks业务开发副总裁兼SCA咨询管理顾问。梁先生拥有芝加哥大学布斯商学院的工商管理硕士学位和双学位,并拥有西北大学的经济学学士学位和国际研究学士学位。